RxDoctor Payments Data

Vishaal Mehra

Psychiatry · San Diego, CANPI 1144472754

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,480 of the $1,480 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, F. Hoffmann-la Roche AG.

$1,480in general payments, 2019–2025

Across 1 payment — averaging $1480.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$1K
$1,024,065in research payments, 2019–2025

Across 172 payments — averaging $5953.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$423K
  • AbbVie$306K
  • Roche TCRC, Inc.$96K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52K
  • Tolmar, Inc.$43K
  • Takeda Pharmaceuticals U.S.A., Inc.$29K
  • plus $75K from 5 others

What the payments were for

  • Consulting fees$1,480100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
F. Hoffmann-la Roche AG1$1,480

How this compares

$1,480 in reported general payments places this provider in the 80th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →